#24-111 Notification of amendments to the rulebook for Nordic MTF
Reading Time: < 1 minute Notification of amendments to the rulebook for Nordic MTF Nordic Growth Market NGM AB (“NGM”) has conducted a review of the rulebook for Nordic MTF (the “Rulebook”) in order to improve market transparency and resilience by establishing more stringent
Animal Care Secures New Sale in Germany, Expanding Support for Veterinary Clinics Treating Domestic Animals
Reading Time: 2 minutes Scandinavian ChemoTech’s Animal Care is pleased to announce a recent sale of its vetIQure™ TSE device with treatment kits to veterinary practice Christoph Sonntag in Germany specializing in the care of domestic animals, with a focus on dogs and cats.
Aker Solutions ASA: Notice of Extraordinary General Meeting
Reading Time: < 1 minute November 1, 2024 – An extraordinary general meeting of Aker Solutions ASA will be held on Friday November 22, 2024, at 12:30 CET. The general meeting will be held as a digital meeting only, with no physical attendance for shareholders.
#24-375 Listing of Derivatives at NGM
Reading Time: < 1 minute Information about various derivatives that will be listed at NGM. For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market
Nordea Bank Abp: Repurchase of own shares on 31.10.2024
Reading Time: < 1 minute Nordea Bank AbpStock exchange release – Changes in company’s own shares31.10.2024 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 31.10.2024 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading venue (MIC Code) Number of shares Weighted average
Eisai completes rolling BLA submission for subcutaneous maintenance dosing of Leqembi® (lecanemab-irmb) in the US
Reading Time: 4 minutes Stockholm, Sweden November 1, 2024 – BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Eisai has completed the rolling submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for lecanemab-irmb (U.S. brand
HEXPOL acquires 80 percent of the shares in Piedmont Resin Supply LLC, a leading US Nylon compounder
Reading Time: 2 minutes HEXPOL has signed an agreement to acquire 80 percent of the shares in Piedmont Resin Supply, LLC (Piedmont) from the founder Mr. Matt Griffith and Mr. Paul Daniel. Piedmont was founded in 2013 and has grown to become one of the
Lundin Gold Share Capital and Voting Rights Update
Reading Time: < 1 minute VANCOUVER, BC, Oct. 31, 2024 /CNW/ – Lundin Gold Inc. (TSX: LUG; Nasdaq Stockholm: LUG; OTCQX: LUGDF) (“Lundin Gold” or the “Company”) reports the following in accordance with the Swedish Financial Instruments Trading Act. As a result of the
Lucara Share Capital and Voting Rights Update
Reading Time: 2 minutes VANCOUVER, BC, Oct. 31, 2024 /CNW/ – (LUC – TSX, LUC – BSE, LUC – Nasdaq Stockholm) Lucara Diamond Corp. (“Lucara” or the “Company”) reports the following in accordance with the Swedish Financial Instruments Trading Act: The number of issued and outstanding
Fondia Plc: Share repurchase 31.10.2024
Reading Time: < 1 minute Fondia Plc Company release 31.10.2024 at 6.45 p.m. EET Fondia – Acquisition of own shares 31.10.2024 Fondia Plc First North Finland Date 31.10.2024 Exchange transactions Buy Share class FONDIA Amount, shares 276 Average price/share, EUR 6,092029